Market Tracker

01/16 5:46am ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.79
Delayed Data
As of Jan 13
 +0.03 / +1.09%
Today’s Change
1.83
Today|||52-Week Range
26.70
+43.81%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.76
Today’s open2.73
Day’s range2.71 - 2.87
Volume177,546
Average volume (3 months)383,721
Market cap$26.5M
Dividend yield--
Data as of 4:00pm ET, 01/13/2017

Growth & Valuation

Earnings growth (last year)-198.92%
Earnings growth (this year)+41.73%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+44.44%
P/E ratioNM
Price/Sales0.89
Price/Book0.52

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc+0.01+0.49%
VKTXViking Therapeutics ...-0.05-3.52%
MBRXMoleculin Biotech In...-0.10-4.15%
ABIOARCA Biopharma Inc-0.10-3.51%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$3.15
Annual revenue (last year)$175.9M
Annual profit (last year)-$148.3M
Net profit margin-84.34%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
President, Chief Financial Officer &
Director
Graham G. Miao
Corporate headquarters
Morristown, New Jersey

Forecasts